A dried blood spots technique based LC-MS/MS method for the analysis of posaconazole in human whole blood samples

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 30, 2011, Pages 3626-3638

  Reddy, Todime M ^a   Tama, Cristina I ^a   Hayes, Roger N ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Dried blood spots (DBSs); LC MS MS; Posaconazole; UPLC

Indexed keywords

ACCURACY AND PRECISION; AHLSTROM; ANALYTES; BLOOD SAMPLES; CONCENTRATION RANGES; DRIED BLOOD SPOTS; HUMAN BLOOD SAMPLES; INTERNAL STANDARDS; LC-MS/MS; MATRIX COMPONENTS; MOBILE PHASE; POSACONAZOLE; POSITIVE ION MODE; TANDEM MASS SPECTROMETRIC; TRIPLE QUADRUPOLE; TURBOIONSPRAY; VALIDATION RESULTS; WHOLE BLOOD;

ACETONITRILE; FORMIC ACID; LIQUID CHROMATOGRAPHY; POSITIVE IONS;

BLOOD;

ACETONITRILE; METHANOL; POSACONAZOLE;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; DRIED BLOOD SPOT; DRUG STABILITY; DRUG STRUCTURE; HEMATOCRIT; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL;

BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, LIQUID; DESICCATION; DRUG STABILITY; HEMATOCRIT; HUMANS; LINEAR MODELS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TRIAZOLES;

EID: 80555122764     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.10.008     Document Type: Article

References (54)

1. Chace D., et al. Clin. Chem. 1993, 39:66.
2. Guthrie R., Susi A. Pediatrics 1963, 32:338.
3. Mei J.V., et al. J. Nutr. 2001, 131:1631S.
4. Li W., Tse F.L. Biomed. Chromatogr. 2010, 24:49.
5. Beaudette P., Bateman K.P. J. Chromatogr. B 2004, 809:153.
6. Edelbroek P.M., Heijden J.v.d., Stolk L.M.L. Ther. Drug Monit. 2009, 31:327.
7. Spooner N., Lad R., Barfield M. Anal. Chem. 2009, 81:1557.
8. Barfield M., et al. J. Chromatogr. B 2008, 870:32.
9. Tawa R., Matsunaga H., Fujimoto T. J. Chromatogr. A 1998, 812:141.
10. Posyniak A., Zmudzki J., Niedzielska J. J. Chromatogr. B 2002, 780:309.
11. AbuRuz S., Millership J., McElnay J. J. Chromatogr. B 2006, 832:202.
12. Allanson A.L., et al. J. Pharm. Biomed. Anal. 2007, 44:963.
13. Blessborn D., et al. J. Pharm. Biomed. Anal. 2007, 45:282.
14. Hoogtanders K., et al. J. Pharm. Biomed. Anal. 2007, 44:658.
15. Ntale M., et al. J. Chromatogr. B 2007, 859:137.
16. Malm M., Lindegårdh N., Bergqvist Y. J. Chromatogr. B 2004, 809:43.
17. Coombes E.J., et al. Ann. Clin. Biochem. 1984, 21:519.
18. Oliveira E.J., Watson D.G., Morton N.S. J. Pharm. Biomed. Anal. 2002, 29:803.
19. Liang X., et al. J. Chromatogr. B 2009, 877:799.
20. Kauffman C.A., et al. Nat. Rev. Drug Discov. 2007, 6:183.
21. Boucher H.W., et al. Drugs 2004, 64:1997.
22. Herbrecht R. Int. J. Clin. Pract. 2004, 58:612.
23. Keating G.M. Drugs 2005, 65:1553.
24. Vazquez J.A., et al. Clin. Infect. Dis. 2006, 42:1179.
25. Greenberg R.N., et al. Antimicrob. Agents Chemother. 2006, 50:126.
26. van Burik J.A., et al. Clin. Infect. Dis. 2006, 42:e61.
27. Raad I.I., et al. Clin. Infect. Dis. 2006, 42:1398.
28. Wexler D., et al. Eur. J. Pharm. Sci. 2004, 21:645.
29. Srinivas T.R., Meier-Kriesche H.U., Kaplan B. Am. J. Transplant. 2005, 5:207.
30. Gubbins P.O., et al. Antimicrob. Agents Chemother. 2006, 50:1993.
31. Neubauer W., et al. J. Chromatogr. B 2009, 877:2493.
32. Tintillier M., et al. Nephrol. Dial. Transplant. 2005, 20:664.
33. Gordien J.B., et al. J. Pharm. Biomed. Anal. 2009, 50:932.
34. Chhun S., et al. J. Chromatogr. B 2007, 852:223.
35. Kahle K., et al. Antimicrob. Agents Chemother. 2009, 53:3140.
36. Storzinger D., et al. Clin. Chem. Lab. Med. 2008, 46:1747.
37. Müller C., et al. Mycoses 2006, 49:17.
38. Shen J.X., Krishna G., Hayes R.N. J. Pharm. Biomed. Anal. 2007, 43:228.
39. Cunliffe J.M., et al. J. Pharm. Biomed. Anal. 2009, 50:46.
40. Shen J.X., Tama C.I., Hayes R.N. J. Chromatogr. B 2006, 843:275.
41. Krüger R., et al. Clin. Chem. Lab. Med. 2010, 48:1723.
42. Verdier M.C., et al. Clin. Chem. Lab. Med. 2010, 48:1515.
43. Vogeser M., et al. Clin. Chem. Lab. Med. 2009, 47:579.
44. Chahbouni A., et al. Ther. Drug Monit. 2010, 32:453.
45. Alffenaar J.W.C., et al. J. Chromatogr. B 2010, 878:39.
46. Bowen R.A.R., et al. Clin. Biochem. 2010, 43:4.
47. Daves M., Trevisan D., Cemin R. J. Clin. Lab. Anal. 2008, 22:391.
48. O'Keane M.P., Cunningham S.K. Clin. Chem. Lab. Med. 2006, 44:662.
49. Bush V.J., et al. Clin. Chim. Acta 2001, 306:139.
50. Dasgupta A., Yared M.A., Wells A. Ther. Drug Monit. 2000, 22:427.
51. Viswanathan C.T., et al. Pharm. Res. 2007, 24:1962.
52. Bansal S., DeStefano A. AAPS J. 2007, 9:E109.
53. FDA Guidance for Industry Bioanalytical Method Validation 2001.
54. Denniff P., Spooner N. Bioanalysis 2010, 2:1385.